Insider selling at 0.03% of market cap is too small to shift the fundamental outlook. The cluster includes the CFO and two other senior execs but lacks the proportionality to signal material adverse news. Ignore on a standalone basis; watch for any correlated catalysts (earnings, pipeline data) in the next 30 days that could explain the timing.
EXEL drugs
EXEL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 26 $49.94entry
- T+1 · 6mo ago −0.24%α −0.25% · $49.82
- T+5 · 6mo ago −2.90%α −4.12% · $48.49
- T+20 · 5mo ago +2.81%α +5.07% · $51.34
- T+60 · 3mo ago +8.92%α +6.45% · $54.39
Price Chart
How similar events traded
Executive Summary
Three senior executives at Exelixis (CFO, EVP Commercial, SVP/GC) collectively sold $3.68M in open-market shares within a week, while CEO Morrissey gifted 124K shares for $0. The sales represent ~0.03% of the $12.5B market cap, trivial from a proportionality standpoint. No 10b5-1 pattern or blackout-window avoidance is evident, but dollar magnitude is immaterial relative to company size, consistent with routine portfolio diversification rather than informed selling.
Key Financial Metrics
Key Facts
- CFO Senner sold 34.9K shares for ~$1.75M on May 18 at $50.21
- EVP Commercial Haley sold 32.1K shares for ~$1.60M on May 20 at $49.81
- SVP/GC Hefti sold 6.6K shares for ~$333K on May 18 at $50.21
- CEO Morrissey gifted 124K shares ($0 cash), non-economic, neutral
- Total open-market sales of ~$3.68M equal ~0.03% of Exelixis' $12.5B market cap
Financial Impact
Insider selling of ~$3.68M, less than 0.03% of market cap; immaterial
Risk Factors
- Subsequent larger sales or unexpected regulatory/pipeline news could retroactively color this cluster as informed
- CEO's large gift (124K shares) could precede a hedging or sale by the recipient, adding future selling pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EXEL-1779483728011 |
Track record
16 reports on EXEL
0 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +21.97% at T+60 after the Feb 28, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 9, 20266d ago SC 13G Neutral 3/10 Entry $70.58 to $70.70 Now $67.10 −4.93% ▲ +0.17% −1.15% vs SPY
- Nov 9, 20266d ago SC 13D/A Bearish 5/10 Entry $70.58 to $70.70 Now $67.10 +4.93% ▼ −0.17% +1.15% vs SPY
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $69.39 to $70.13 Now $67.10 −3.30% ▲ +1.07% +1.55% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 2/10 Entry $64.58 to $65.31 Now $67.10 +3.90% ▲ +1.13% +2.31% vs SPY
- Oct 12, 20265w ago Institutional Cluster Neutral 3/10 Entry $59.82 to $59.51 Now $67.10 +12.17% ▼ −0.52% −0.51% vs SPY
- Sep 11, 20269w ago 8-K Bearish 6/10 Entry $56.12 to $56.21 Now $67.10 −19.57% ▼ −0.16% −0.61% vs SPY
- Jun 3, 202623w ago Insider Cluster Neutral 2/10 Entry $52.39 to $52.69 Now $67.10 +28.08% ▲ +0.57% +3.17% vs SPY
- May 29, 202624w ago 8-K Neutral 3/10 Entry $50.20 to $48.49 Now $67.10 +33.67% ▼ −3.41% −3.55% vs SPY
- May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 Now $67.10 +33.35% ▼ −0.08% −0.35% vs SPY
- May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 Now $67.10 +33.35% ▼ −0.08% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers